The Ministry of Health and Welfare and the Korea Health Industry Development Institute opened a C&D (connect and develop) incubation center at the Cambridge Innovation Center (CIC) in Boston, Mass., on Wednesday (EST).The ministry and the institute set up the C&D incubation center, named Korea Bio-I
An AI-based 3D brain MRI device that helps diagnose neurodegenerative diseases won national health insurance coverage for the first time in Korea.Vuno, a medical tech startup, said Thursday that its AI-backed brain quantification device, VUNO Med-DeepBrain, obtained the Health Insurance Review and A
TiumBio, a Korean biotech company focusing on cancer and rare diseases, said it would participate in the 2022 BIO International Convention (BIO USA) to discuss partnerships with multinational drugmakers and biotech firms.BIO USA is the world’s largest biotech and pharmaceutical partnering event. Thi
List Biotherapeutics, a U.S. subsidiary of Genome & Company, said that it has started the construction of its microbiome treatment production facility in Fishers City, Ind.Established in October 2020, List Biotherapeutics plans to build a large-scale microbiome production facility in Fishers Life Sc
With the recent designation of monkeypox as a second-degree infectious disease out of a four-tier system, the medical community should set up a monitoring system to detect monkeypox cases early and secure third-generation smallpox vaccines and treatments swiftly, an expert said.In particular, he sai
The number of electric scooter accidents is rising every year, and the government should introduce a system for renting a helmet along with an electric scooter to prevent craniofacial trauma, a medical paper said.A research team at the Department of Plastic and Reconstructive Surgery of Chonnam Nati
Celltrion Pharmaceutical said it would exclusively market two diabetes treatment lineups – Nesina and Actos – it took over from Takeda Pharmaceutical. Jeil Pharmaceutical has marketed the two treatments.Celltrion has decided to end the joint sales contract at the end of this month and start direct s
On Wednesday, the health authorities designated monkeypox as a second-degree legal infectious disease out of a four-tier system, as the disease is spreading fast around the globe.Currently, 22 diseases, including Covid-19, tuberculosis, and chickenpox, are grouped as the second-level contagious dise
Starting Wednesday, all international arrivals will not have to isolate themselves for a week whether they received Covid-19 vaccines or not and whether they are Koreans or foreigners.According to officials at the Central Disease Control Headquarters, the lifting of mandatory seven-day self-quaranti
JW Bioscience said Wednesday that it launched a 125-gram ultra-lightweight, portable pneumatometer called “Chestmate” and will soon begin marketting it .Chestmate is a portable device to measure lung capacity equipped with an LCD touch screen, which diagnoses lung function of patients with respirato
Korea AI Center for Drug Discovery and Development (KAICD) said Wednesday that it would recruit expert instructors to develop and teach artificial intelligence (AI) to facilitate drug discovery and practical cooperative research.As an affiliated organization of the Korea Pharmaceutical and Bio-Pharm
Researchers at Seoul National University Bundang Hospital (SNUBH) have found that when they perform “vocal cord injections” to improve patients’ voices by correcting their vocal cords, using a light-guided method is easier and more effective.According to the research team, led by Professor Cha Won-j
Developers of digital therapeutics (DTx) need to embrace regulation as a “necessary evil” and work with clinicians from the beginning of development to pass the regulatory procedure, said an expert who developed FDA-authorized DTx.Jessica Lake, Chief Science Officer (CSO) of Limbix, spoke on dealing
CHICAGO, Ill. – The use of Yuhan Corp.’s anticancer drug Leclaza (lazertinib) in combination with Janssen’s Rybrevant (amivantamab), a bispecific antibody targeting EGFR and MET, drew much attention from international oncologists.At the annual meeting of the American Society of Clinical Oncology in
Johnson & Johnson Innovation and Janssen Korea launched the sixth “Seoul Innovation QuickFire Challenge: Scientific Advancements of Tomorrow” in collaboration with the Seoul Metropolitan Government (SMG) and the Korea Health Industry Development Institute (KHIDI).J&J’s QuickFire Challenge aims to ad
CHICAGO, Ill. – A breast cancer study outcome was so impressive that it received a standing ovation at the American Society of Clinical Oncology (ASCO 2022), the world’s largest meeting in oncology being held in Chicago.The standing ovation went to researchers of phase 3 DESTINY-Breast04 trial of En
The number of patients registered for phase 3 clinical trials of GNT Pharma’s stroke treatment, Nelonemdaz, has exceeded 100, raising expectations for completing all related trials in 2023 as scheduled, the company said Tuesday.Nelonemdaz is the first drug candidate worldwide that received approval
Macrogen, a precision medical biotechnology business, celebrated its 25th anniversary last Friday, unveiling its plan to open the “Macrogen 2.0 era” through high-speed growth and leaping to the digital healthcare business.To this end, Macrogen said it would focus on diversifying its business portfol
For the proposed Infectious Disease Central Hospital (CIDH) to serve as a control tower in a pandemic crisis, an expert said it needs to invest intensively into “software” to strengthen internal capacity, including high-quality staffing.In 2017, the Ministry of Health and Welfare concluded that it i
Korea’s new Covid-19 cases showed a decline for the 11th consecutive week in the first week of June, with teens and 20-somethings showing the highest incidence, health officials said Tuesday.In contrast, both infection rate and share fell among the high-risk group of adults 60 and older as they bega